The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
Open accessAbstract
Tumor necrosis factor (TNF) alpha is a cytokine that has potent immune regulatory functions. To assess the potential role of this cytokine in the early development of autoimmunity, we investigated the effect of TNF on the development of insulin-dependent diabetes mellitus (IDDM) in nonobese diabetic (NOD) mice, a spontaneous murine model for autoimmune, insulin-dependent type I diabetes. Treatment of newborn female NOD mice with TNF every other day for 3 wk, led to an earlier onset of disease (10 versus 15 wk of age in control mice) and 100% incidence before 20 wk of age (compared to 45% at 20 wk of age in control phosphate-buffered saline treated female mice). In contrast, administration of an anti-TNF monoclonal antibody, TN3.19.12, resulted in complete prevention of IDDM. In vitro proliferation assays demonstrated that mice treated with TNF developed an increased T cell response to a panel of beta cell autoantigens, whereas anti-TNF treatment resulted in unresponsiveness to the autoantigens. In addition, autoantibody responses to the panel of beta cell antigens paralleled the T cell responses. The effects mediated by TNF appear to be highly age dependent. Treatment of animals either from birth or from 2 wk of age had a similar effect. However, if treatment was initiated at 4 wk of age, TNF delayed disease onset. These data suggest that TNF has a critical role in the early development of autoimmunity towards beta-islet cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.625 · Cited by 1,697
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Tartaglia, L. A., & Goeddel, D. V. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90116-o · Cited by 1,035
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. (1994) · Science · doi:10.1126/science.8171322 · Cited by 986
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
Tisch, R., Yang, X.-D., Singer, S. M., Liblau, R. S., Fugger, L., & McDevitt, H. O. (1993) · Nature · doi:10.1038/366072a0 · Cited by 949
Self-citationLeukocyte adhesion to endothelium in inflammation
Osborn, L. (1990) · Cell · doi:10.1016/0092-8674(90)90230-c · Cited by 865
Interleukin-12 and its role in the generation of TH1 cells
Trinchieri, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90230-i · Cited by 845
Following a diabetogenic T cell from genesis through pathogenesis
Katz, J. D., Wang, B., Haskins, K., Benoist, C., & Mathis, D. (1993) · Cell · doi:10.1016/0092-8674(93)90730-e · Cited by 696
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
Self-citationCytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 408
Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice
Wicker, L. S., Miller, B. J., & Mullen, Y. (1986) · Diabetes · doi:10.2337/diab.35.8.855 · Cited by 381
Sheehan, K. C. F., Ruddle, N. H., & Schreiber, R. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3884 · Cited by 379
Self-citationJacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., & Acha-Orbea, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.968 · Cited by 349
Self-citationA role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., & Lo, D. (1994) · Immunity · doi:10.1016/1074-7613(94)90011-6 · Cited by 338
Self-citationPukel, C., Baquerizo, H., & Rabinovitch, A. (1988) · Diabetes · doi:10.2337/diab.37.1.133 · Cited by 290
Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages
Hutchings, P., Rosen, H., O'Reilly, L., Simpson, E., Gordon, S., & Cooke, A. (1990) · Nature · doi:10.1038/348639a0 · Cited by 245
Evidence for Initial Involvement of Macrophage in Development of Insulitis in NOD Mice
Lee, K.-U., Amano, K., & Yoon, J.-W. (1988) · Diabetes · doi:10.2337/diab.37.7.989 · Cited by 235
IFN- gamma and tumor necrosis factor- alpha . Cytotoxicity to murine islets of Langerhans.
Campbell, I. L., Iscaro, A., & Harrison, L. C. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2325 · Cited by 233
Hänninen, A., Taylor, C., Streeter, P. R., Stark, L. S., Sarte, J. M., Shizuru, J. A., Simell, O., & Michie, S. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116859 · Cited by 217
Autoantibodies to cytokines - friends or foes?
Bendtzen, K., Svenson, M., Jønsson, V., & Hippe, E. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90068-k · Cited by 209
Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.
Fraker, D. L., Stovroff, M. C., Merino, M. J., & Norton, J. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.1.95 · Cited by 196
Satoh, J., Seino, H., Abo, T., Tanaka, S., Shintani, S., Ohta, S., Tamura, K., Sawai, T., Nobunaga, T., & Oteki, T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114304 · Cited by 180
IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.
Doukas, J., & Pober, J. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1727 · Cited by 172
Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H., & Flavell, R. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.4136 · Cited by 168
Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice
Gordon, C., Ranges, G. E., Greenspan, J. S., & Wofsy, D. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90157-8 · Cited by 167
Ranges, G. E., Zlotnik, A., Espevik, T., Dinarello, C. A., Cerami, A., & Palladino, M. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1472 · Cited by 158
Higuchi, Y., Herrera, P. L., Muniesa, P., Huarte, J., Belin, D., Ohashi, P. S., Aichele, P., Orci, L., Vassalli, J. D., & VASSALLI, P. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1719 · Cited by 148
Yang, X., Karin, N., Tisch, R., Steinman, L., & McDevitt, H. O. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10494 · Cited by 141
Self-citationPatton, J. S., Peters, P. M., McCabe, J., Crase, D., Hansen, S., Chen, A. B., & Liggitt, D. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113245 · Cited by 131
Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning
Dardenne, M., Lepault, F., Bendelac, A. S., & Bach, J. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190516 · Cited by 117
OGAWA, M., MURAYAMA, T., Hasegawa, T., KANAYA, T., Kobayashi, F., Tochino, Y., & Uda, H. (1985) · Biomedical Research · doi:10.2220/biomedres.6.103 · Cited by 100
Constitutive synthesis of tumor necrosis factor in the thymus.
Giroir, B. P., Brown, T., & Beutler, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4864 · Cited by 96
Bemelmans, M. H. A., Gouma, D. J., & Buurman, W. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5554 · Cited by 84
Eizirik, D. L. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1190321 · Cited by 78
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
Tisch, R., Yang, X., Singer, S. M., Liblau, R., Fugger, L. H., McDevitt, H. O., Cooke, A., & Mandel, T. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347755 · Cited by 75
Self-citationHansen, M. B., Svenson, M., Diamant, M., & Bendtzen, K. (1993) · Cytokine · doi:10.1016/1043-4666(93)90026-2 · Cited by 65
Progression From Insulitis to β-Cell Destruction in NOD Mouse Requires L3T4+ T-Lymphocytes
Charlton, B., & MANDEL, T. E. (1988) · Diabetes · doi:10.2337/diab.37.8.1108 · Cited by 63
Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development.
Kossodo, S. D., Grau, G. E., Daneva, T., Pointaire, P., Fossati, L., Ody, C., Zapf, J., Piguet, P. F., Gaillard, R., & VASSALLI, P. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1259 · Cited by 62
MHC Molecules and β-Cell Destruction: Immune and Nonimmune Mechanisms
Harrison, L. C., Campbell, I. L., Allison, J., & MILLER, J. F. A. P. (1989) · Diabetes · doi:10.2337/diab.38.7.815 · Cited by 51
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F. M., & Coffman, R. L. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90202-u · Cited by 49
Jacob, C. O., Aiso, S., Schreiber, R. D., & McDevitt, H. O. (1992) · International Immunology · doi:10.1093/intimm/4.5.611 · Cited by 44
Self-citationRabinovitch, A., Baquerizo, H., Pukel, C. S., & SUMOSKI, W. (1989) · PubMed · Cited by 21
Cited by
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
β-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
The −308 tumor necrosis factor-α promoter polymorphism effects transcription
Kroeger, K. M., Carville, K. S., & Abraham, L. J. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00052-7 · Cited by 864
Metadata
- Authors
- Yang, X. D., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D., & McDevitt, H. O.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-09-01
- Volume
- 180
- Issue
- 3
- Pages
- 995-1004
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2145591227
- Cited by
- 303
- References
- 45
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.